Oeronkliniken Stockholm AB
- Address
- Valhallavagen 91, Engelbrekt, 114 28 Stockholm, Sweden
Öronkliniken Stockholm AB - Rhinology & Upper Airway Research Center
Öronkliniken Stockholm AB specializes in advanced clinical research focused on chronic upper airway disorders and rhinological conditions. The center demonstrates particular expertise in investigating novel immunological therapies for complex inflammatory conditions affecting the nasal passages and sinuses.
- Chronic rhinosinusitis with nasal polyps treatment strategies
- Anti-IL-33 monoclonal antibody therapies for upper airway inflammation
- Advanced therapeutic interventions for inadequately-controlled sino-nasal conditions
The research center actively participates in Phase 3 clinical trials evaluating cutting-edge biologic therapies targeting specific inflammatory pathways. Their work focuses on assessing both efficacy and safety profiles of novel treatments, with particular attention to patient-reported outcomes such as nasal congestion relief and objective measures including nasal polyp size reduction in patients with difficult-to-treat chronic conditions.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 188 other sites in Sweden
Therapeutic Area Benchmark — Sweden
Select a therapeutic area to compare against other sites in Sweden.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Sweden
Market Share
Country: Sweden
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Oeronkliniken Stockholm AB
lock Showing 1 of 2 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Long‑Term Safety and Tolerability of Subcutaneous Itepekimab in Adults with Inadequately Controlled Chronic Rhinosinusitis with Nasal Polyps: Double‑Blind Extension Study | Sanofi-Aventis Recherche & Developpement | Phase III | Recruiting | Jun 2026 | — |
IMP list
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Itepekimab | 2 | Unknown | 2025-05-20 | 2026-06-23 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.